There was no statistically significant distinction observed between the ESCC group and other EC groups (such as esophageal adenocarcinoma, sarcoma, endocrine carcinoma, etc.), suggesting that CST1 may not exhibit specific elevation in ESCC compared to other types of esophageal malignant tumors. This evidence concerns the gene CST1 and esophageal squamous cell carcinoma.